Skip to main content

Advertisement

ADVERTISEMENT

Ankylosing Spondylitis News

News
07/16/2020
Patients with inflammatory arthritis who switched from a first-line to a second-line subcutaneous tumor necrosis factor alpha inhibitor incurred significantly higher nontreatment health care resource utilization costs 12 months after the...
Patients with inflammatory arthritis who switched from a first-line to a second-line subcutaneous tumor necrosis factor alpha inhibitor incurred significantly higher nontreatment health care resource utilization costs 12 months after the...
Patients with inflammatory...
07/16/2020
First Report Managed Care
News
07/19/2017
Patients with ankylosing spondylitis (AS) who start taking statins live longer than those who aren’t on the cholesterol-lowering drugs, according to a new population-based cohort study.
Patients with ankylosing spondylitis (AS) who start taking statins live longer than those who aren’t on the cholesterol-lowering drugs, according to a new population-based cohort study.
Patients with ankylosing...
07/19/2017
First Report Managed Care
News
11/15/2016
Recent clinical trial results showed that Simponi Aria (golimumab; Janssen) significantly improved symptoms among patients with active ankylosing spondylitis.
Recent clinical trial results showed that Simponi Aria (golimumab; Janssen) significantly improved symptoms among patients with active ankylosing spondylitis.
Recent clinical trial results...
11/15/2016
First Report Managed Care

Advertisement

News
11/15/2016
Patients with ankylosing spondylitis or psoriatic arthritis who take statins have a considerably lower risk of early death compared with those not on the drugs, according to a new study.
Patients with ankylosing spondylitis or psoriatic arthritis who take statins have a considerably lower risk of early death compared with those not on the drugs, according to a new study.
Patients with ankylosing...
11/15/2016
First Report Managed Care
News
02/18/2015
The recent AQUILES study sought to examine the incidence of extra-articular manifestations, including uveitis, psoriasis, and inflammatory bowel disease (IBD), in patients with ankylosing spondylitis (AS) [Rheumatol Clin. 2015;...
The recent AQUILES study sought to examine the incidence of extra-articular manifestations, including uveitis, psoriasis, and inflammatory bowel disease (IBD), in patients with ankylosing spondylitis (AS) [Rheumatol Clin. 2015;...
The recent AQUILES study sought...
02/18/2015
First Report Managed Care
News
02/02/2015
There are 2 forms of axial spondyloarthritis (SpA): (1) ankylosing spondylitis (AS); and (2) nonradiographic axial SpA (nr-axSpA). Although patients with either form may be similar in demographics and disease activity, little information is...
There are 2 forms of axial spondyloarthritis (SpA): (1) ankylosing spondylitis (AS); and (2) nonradiographic axial SpA (nr-axSpA). Although patients with either form may be similar in demographics and disease activity, little information is...
There are 2 forms of axial...
02/02/2015
First Report Managed Care

Advertisement

News
11/21/2014
Golimumab, given every four weeks, improves long-term clinical outcomes in patients with ankylosing spondylitis.
Golimumab, given every four weeks, improves long-term clinical outcomes in patients with ankylosing spondylitis.
Golimumab, given every four...
11/21/2014
First Report Managed Care

Advertisement